Passive immunization against highly pathogenic Avian Influenza Virus (AIV) strain H7N3 with antiserum generated from viral polypeptides protect poultry birds from lethal viral infection
Open Access
- 28 November 2008
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 5 (1) , 144
- https://doi.org/10.1186/1743-422x-5-144
Abstract
Our studies were aimed at developing a vaccination strategy that could provide protection against highly pathogenic avian influenza virus (AIV), H7N3 or its variants outbreaks. A purified viral stock of highly pathogenic H7N3 isolate was lysed to isolate viral proteins by electrophresing on 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), followed by their elution from gel through trituration in phosphate buffered saline (PBS). Overall, five isolated viral polypeptides/proteins upon characterization were used to prepare hyperimmune monovalent serum against respective polypeptides independently and a mixture of all five in poultry birds, and specificity confirmation of each antiserum through dot blot and Western blotting. Antiserum generated from various group birds was pooled and evaluated in 2-week old broiler chicken, for its protection against viral challenge. To evaluate in-vivo protection of each antiserum against viral challenges, six groups of 2-week old broiler chicken were injected with antiserum and a seventh control group received normal saline. Each group was exposed to purified highly pathogenic AIV H7N3 strain at a dose 105 embryo lethal dose (ELD50). We observed that nucleoprotein (NP) antiserum significantly protected birds from viral infection induced morbidity, mortality and lowered viral shedding compared with antiserum from individual viral proteins or mixed polypeptides/proteins inclusive of NP component. The capability of individual viral polypeptide specific antisera to protect against viral challenges in decreasing order was nucleoprotein (NP) > hemagglutinin (HA) > neuraminidase (NA) > viral proteins mix > viral polymerase (PM) > non-structural proteins (NS). Our data provide proof of concept for potential utilization of passive immunization in protecting poultry industry during infection outbreaks. Furthermore conserved nature of avian NP makes it an ideal candidate to produce antiserum protective against viral infection.Keywords
This publication has 20 references indexed in Scilit:
- Antibodies Targeting Linear Determinants of the Envelope Protein Protect Mice against West Nile VirusThe Journal of Infectious Diseases, 2007
- Influence of Virus Strain on the Efficacy of Vaccine Against Avian Influenza Virus Subtype H7N3International Journal of Poultry Science, 2007
- Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptideMicrobes and Infection, 2007
- Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza VirusJournal of Virology, 2007
- Summary of Avian Influenza Activity in Europe, Asia, Africa, and Australasia, 2002–2006Avian Diseases, 2007
- Avian Influenza in Pakistan: Outbreaks of Low- and High-Pathogenicity Avian Influenza in Pakistan During 2003–2006Avian Diseases, 2007
- Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccinesVaccine, 2006
- Overview of avian influenza DIVA test strategiesBiologicals, 2005
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutininVirology, 1988